Instant-View Marijuana Drug Test
As Low as .81 each
The Marijuana Rapid Drug Test Cassette (case of 25) is CLIA Waived & FDA 510K #K063545, simply dip the card in urine and read results in 4 minutes. - The Instant-View® Marijuana (THC) urine drug test is a rapid (simply dip in urine and read at 4 minutes), a one step immunoassay designed to detect 11-nor-delta-9 THC-9-carboxylic acid (THC) in human urine at a cut-off level of 50 ng/ml. Tetrahydrocannabinols (THC, delta-9-THC, delta-1-THC) are the most active of the principle constituents, as well as the major metabolites, of cannibinoids such as marijuana and hashish. Cannibinoids are used as central nervous system depressants and can be detectable in urine for 2-5 days (casual use) and 14-30 days (chronic use).
The Instant-View® Marijuana (THC) urine drug test detects THC in order to evaluate the abuse of cannibinoids. The test is for healthcare professional use only and provides qualitative screening test results. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. The test is available in cassette and dip strip formats, with the option of being included in the Instant-View® multi-drug screen test.
Marijuana (THC) urine cassette and dip strip test
Method
Lateral flow test
Cut-off level
50 ng/ml
Accuracy
cassette: >96.4%
dip strip: >95.9%
Precision
cassette: 96.70%
dip strip: 98.80%
Sample
Urine
Read time
4-7 minutes
Storage
Room temperature
Shelf life
24 months from date of manufacture
CLIA Classification
Waived
Feature
Benefit
Easy, one-step procedure
Quick results; minimizes user error
24-month shelf life at room temp. (from date of manufacture)
No special storage requirements to maintain stability
Small sample volume required
Tests can be reliably performed with minimal amount of specimen
Available in cassette or dip strip format
Various formats for applying specimen
50 ng/ml cut-off level
Meets SAMHSA standards for substance abuse screening
Assigned CPT Codes
Multiple Classes: 80100QW / G0430
Single Class: 80101QW / G0431
Recognized by Medicare for reimbursement
Made in U.S.A.
Consistent, on-time supply & ready technical support
-Catalog #: 03-3571
-Quantity: 25 Tests
FDA 510K & CLIA Waived
CPT Code: G0431-QW - Drug screen, qualitative; single drug class method (eg, immunoassay, enzyme assay), each drug class - avg reimbursement $19.72
NOTE: Its is always the healthcare provider's responsibility to establish reimbursement amount.
